Vitalhub (TSE:VHI) Given a C$15.00 Price Target by Royal Bank Of Canada Analysts

Key Points

• Royal Bank of Canada has set a target price of C$15.00 for Vitalhub (TSE:VHI), indicating a potential upside of 29.65% from the stock's previous close.
• Multiple analysts have given Vitalhub an "outperform" rating, with consensus price targets ranging from C$14.21 to C$16.00.
• Insider selling has been noted, with Director Danny Matlow selling 150,000 shares, reducing his ownership by 22.39%.

Vitalhub (TSE:VHI - Get Free Report) has been given a C$15.00 price objective by analysts at Royal Bank Of Canada in a research note issued on Thursday, MarketBeat reports. The brokerage presently has an "outperform" rating on the stock. Royal Bank Of Canada's price target indicates a potential upside of 30.78% from the company's previous close.

Other equities research analysts have also issued research reports about the stock. National Bank Financial upgraded shares of Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th. National Bankshares set a C$16.00 price target on shares of Vitalhub and gave the company an "outperform" rating in a research note on Thursday, August 21st. TD Securities raised their price target on shares of Vitalhub from C$15.00 to C$16.00 and gave the company a "buy" rating in a research note on Monday, August 11th. Raymond James Financial raised their price target on shares of Vitalhub from C$14.50 to C$15.00 and gave the company an "outperform" rating in a research note on Tuesday, August 12th. Finally, Scotiabank raised their price target on shares of Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research note on Friday, June 20th. One analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Buy" and an average price target of C$14.21.

Vitalhub Trading Down 2.0%

VHI traded down C$0.24 on Thursday, hitting C$11.47. 179,625 shares of the company's stock were exchanged, compared to its average volume of 152,209. The firm has a market cap of C$720.66 million, a PE ratio of 143.38, a P/E/G ratio of 1.18 and a beta of 0.93. Vitalhub has a twelve month low of C$8.30 and a twelve month high of C$14.64. The stock has a fifty day moving average of C$12.58 and a two-hundred day moving average of C$11.10.

Insider Buying and Selling

In related news, Director Steve Garrington sold 20,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the transaction, the director owned 60,000 shares in the company, valued at C$774,000. This trade represents a 25.00% decrease in their ownership of the stock. Also, Director Danny Matlow sold 150,000 shares of the firm's stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the sale, the director owned 520,001 shares of the company's stock, valued at C$6,630,012.75. The trade was a 22.39% decrease in their ownership of the stock. 18.57% of the stock is owned by company insiders.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.